In 2024, both Novo Nordisk and Eli Lilly said that they were not supplying compounders with the semaglutide and tirzepatide they are selling to their customers
Medications that interfere include certain antidepressants (SSRIs, SNRIs), beta blockers, steroids, and antipsychotics
A clinical trial in Parkinsons disease patients using systemic administrations of the GLP1-R agonist exendin-4 in an extended release formulation has demonstrated clinical efficacy (Athauda et al, 2017)
The appropriate amount depends on the glutathione form, product instructions, health status, and professional guidance
More recently, non-coding RNAs, such as lncRNAs and circRNAs have also been recognized to influence ARs transcription factor in diverse manners [110, 142]
While these findings are encouraging, its important for our patients to understand that robust human clinical trials are still lacking